TSH is an alpha/beta heterodimeric glycoprotein hormone secreted from the anterior pituitary gland which belongs to the glycoprotein hormone family. The actions of TSH are mediated by a seven-transmembrane receptor, which upon TSH binding couples preferentially to the G-alpha (s) protein (Gs), resulting in activation of adenylate cyclase and increase in cyclic adenosine 3', 5' monophosphate (cAMP). The TSH receptor (THSR) is mainly expressed in thyroid follicular cells and regulates their growth and function. This cell based assay was conducted on a TSHR transfected HEK 293 cell line, measuring cAMP stimulation using antibody-based Homogeneous Time Resolved Fluorescence (HTRF). Our goal is to identify small molecules that will inhibit (antagonize) the thyroid-stimulating hormone receptor (TSHR), a member of the 7 transmembrane-spanning receptor (7TMR) family of cell surface receptors. TSHR-mediated hyperthyroidism is important in thyroid pathology.  The development of small molecule antagonists of TSHR may lead to therapeutic approaches for TSHR-mediated hyperthyroidism caused by constitutively activating mutations or stimulating auto-antibodies associated with Graves' disease.  Graves' disease is the leading cause of hyperthyroidism and is caused by autoantibodies that stimulate TSHR (TsAbs) causing thyroid growth and unregulated overproduction of thyroid hormones and existing treatments have liabilities (agranulocytosis). In addition, TSHRs are known to be expressed in multiple extrathyroidal tissues including bone, brain, kidney, testis, fat and cells of the immune system but the role of the TSHR in these tissues is not clear.  Therefore, TSHR antagonists/inverse agonists could be used as probes of extrathyroidal TSHR function. Finally, TSHR inverse agonists, which are a subclass of antagonists that inhibit agonist-independent (or basal or constitutive) TSHR signaling, could be used to inhibit TSH-independent signaling in patients with recurrent or metastatic thyroid cancer who are receiving thyroid hormone to suppress TSH. An anti cAMP antibody contains a fluorescent cryptate tag (excitation 337 nm; emission 620 nm) and the acceptor is cAMP-d2 (excitation 620 nm; emission 665 nm). When antibody and cAMP-d2 interact and are excited by a 337 nm light, a FRET occurs resulting in emission at 665 nm. The assay is competition between cAMP-d2 and cAMP (from the cell lysate). The homogeneous protocol allows for one step dispense after stimulation that is automation friendly. Step, Parameter, Value, Description 1, Cells, 3 uL, 2000 TSHR freshly harvested cells/well 1536 TC treated White solid bottom plate (Cells resuspended in 10 mM HEPES buffered HBSS and 70 uM RO 20-1724) 2, Compound, 23 nL, Libraries and controls 3, Compound, 1 uL, EC80 TSH (4 nM final) 4, Time, 2 hours, 37C 5, Reagent, 2 uL, cAMP antibody diluted 1:20 in lysis buffer 6, Time, 30 minutes, Room temperature 7, Detector, HTRF settings, Viewlux
bao:BAO_0000540 "926" ; # "is confirmatory assay of" -> "926"
bao:BAO_0000812 "488990" ; # "has summary assay" -> "488990"
bao:BAO_0000809 bao:BAO_0000030 ; # "has confirmatory assay" -> "confirmatory assay"
bao:BAO_0000205 bao:BAO_0000219 ; # "has assay format" -> "cell-based format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000284 ; # "has participant" -> "G protein coupled receptor" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 bao:BAO_0000650 ; # "is bioassay type of" -> "cAMP redistribution assay"
bao:BAO_0000212 bao:BAO_0000123 ; # "has assay method" -> "binding assessment method"
bao:BAO_0000212 bao:BAO_0000129 ; # "has assay method" -> "immunoassay"
bao:BAO_0000207 bao:BAO_0000002 ; # "has detection method" -> "homogeneous time resolved fluorescence"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Ligands of the Thyroid Stimulating Hormone receptor (TSH)" ; # "screening campaign name" -> "Ligands of the Thyroid Stimulating Hormone receptor (TSH)"
bao:BAO_0002853 "qHTS Assay for Antagonists of the Thyroid Stimulating Hormone Receptor" ; # "has assay title" -> "qHTS Assay for Antagonists of the Thyroid Stimulating Hormone Receptor"
bao:BAO_0002854 bao:BAO_0000010 ; # "has bioassay type" -> "functional"
bao:BAO_0002867 bao:BAO_0000516 ; # "has assay footprint" -> "1536 well plate"
bao:BAO_0000109 "37 degree celsius" ; # "has temperature value" -> "37 degree celsius"
bao:BAO_0002833 "2 hour" ; # "has incubation time value" -> "2 hour"
bao:BAO_0002020 bao:BAO_0000373 ; # "has assay phase characteristic" -> "heterogeneous phase"
bao:BAO_0002739 "\"D2-labeled cAMP, HTRF acceptor fluorophore D2\"" ; # "has substrate" -> ""D2-labeled cAMP, HTRF acceptor fluorophore D2"" || bao:BAO_0003102 bao:BAO_0002030 ; # "has role" -> "coupled substrate"
bao:BAO_0002000 bao:BAO_0001012 ; # "has measured entity" -> "Ro 20-1724" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35222> ; # "has role" -> "inhibitor"
bao:BAO_0002000 bao:BAO_0001033 ; # "has measured entity" -> "Thyroid-stimulating hormone" || bao:BAO_0003102 bao:BAO_00020138 ; # "has role" -> "potentiator"
bao:BA0_0090012 "Thyrotropin receptor" ; # "has participant" -> "Thyrotropin receptor"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "P16473" ; # "uniprot ID" -> "P16473"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
bao:BAO_0002922 "\"HBSS with 10 mM HEPES, 70 micromolar RO 20-1724\"" ; # "has assay medium" -> ""HBSS with 10 mM HEPES, 70 micromolar RO 20-1724""
bao:BAO_0002922 bao:BAO_0000596 ; # "has assay medium" -> "assay medium"
bao:BAO_0000550 "Expressing Thyroid Stimulating Hormone Receptor (TSH)" ; # "DNA construct" -> "Expressing Thyroid Stimulating Hormone Receptor (TSH)"
bao:BAO_0003105 "thyroid stimulating hormone receptor" ; # "has function" -> "thyroid stimulating hormone receptor"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "7253" ; # "construct gene ID" -> "7253"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BAO_0000502 "\"Europium Eu3+ cryptate-labeled anti-cAMP, HTRF fluorophore donor, Cisbio\"" ; # "antibody" -> ""Europium Eu3+ cryptate-labeled anti-cAMP, HTRF fluorophore donor, Cisbio""
bao:BA0_0090012 bao:BAO_0000875 ; # "has participant" -> "Cyclic adenosine monophosphate"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0002153 ; # "has signal direction" -> "signal increase corresponding to inhibition"
bao:BAO_0000308 bao:BAO_0000937 ; # "has assay kit" -> "HTRF cAMP Detection Kit"
bao:BAO_0000308 bao:BAO_0000248 ; # "has assay kit" -> "assay Kit"
bao:BAO_0000737 bao:BAO_0000881 ; # "has manufacturer" -> "Cisbio" || bao:BAO_0003102 bao:BAO_0002626 ; # "has role" -> "biologics and screening manufacturer"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0002865 bao:BAO_0000691 ; # "uses detection instrument" -> "ViewLux ultraHTS Microplate Imager"
bao:BAO_0000737 bao:BAO_0000297 ; # "has manufacturer" -> "Perkin Elmer" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "337 nanometer" ; # "has excitation wavelength value" -> "337 nanometer"
bao:BAO_0002918 "665 nanometer" ; # "has emission wavelength value" -> "665 nanometer"
bao:BAO_0000208 bao:BAO_0000186 ; # "has endpoint" -> "AC50"
bao:BAO_0000337 bao:BAO_0000656 ; # "has percent response" -> "efficacy"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2" ; # "PubChem TID" -> "2"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "3" ; # "PubChem TID" -> "3"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002787 "7" ; # "has concentration-point number" -> "7"
bao:BAO_0000196 bao:BAO_0000091 ; # "has mode of action" -> "inhibition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "mp" ; # "Annotated by" -> "mp"
